Navigation Links
Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2013
Date:2/7/2013

rrants, net profit for Q3 FY13 would have been US$24.3 million or basic earnings per share ("basic EPS") of 1.41 US cents and diluted earnings per share ("diluted EPS") of 1.39 US cents. This compares to a net profit of US$26.8 million or basic EPS of 1.63 US cents and diluted EPS of 1.60 US cents, for Q3 FY12 after excluding the one-off non-operating gain of $279.6 million on re-measurement of the Group's interest in JWMS, goodwill impairment and the fair value adjustments for warrants.

Including exceptional items, net profit for Q3 FY13 was US$24.9 million, or basic EPS of 1.45 US cents and diluted EPS of 1.43 US cents, compared to a net profit of US$291.5 million, or basic EPS of 17.78 US cents and diluted EPS of 17.42 US cents, for Q3 FY12.

Performance Summary for FY13 Nine-month Period

Total product revenue in the FY13 nine-month period was US$202.1 million, a 38% year-on-year increase from US$146.0 million reported for the fiscal nine months ended 31 December 2011 ("FY12 nine-month period"). IVP revenue rose 42% to US$191.6 million, compared to US$134.9 million for the FY12 nine-month period, primarily driven by the Company's DES sales and the consolidation of JWMS' financial results starting from Q3 FY12. CCP revenue was US$10.5 million, a 6% decrease from the US$11.2 million for the FY12 nine-month period.

Overall total operating expenses accounted for 46% of total revenue in the nine months of FY13, compared to 45% for the FY12 nine-month period. S&M expense was US$66.2 million, G&A expense was US$29.2 million, while R&D expense was US$17.5 million.

For the FY13 nine-month period, the Group's operating profit was US$94.7 million, representing a 34% year-on-year increase from the same period last year.

Financial Guidance for FY13

Year-to-date, the Company has achieved healthy growth in its product sales, in line with the original target. However, due to changes in the dynamics of the Japanese marke
'/>"/>

SOURCE Biosensors International Group, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Biosensors Reports Strong Sales and Profitability in the First Quarter of Fiscal Year 2013
2. Sigma-Aldrich Reports Record Full Year 2012 Results. Reports Q4 2012 Diluted EPS Of $0.96. Q4 2012 Sales Increased 7%. Full Year 2012 Adjusted Diluted EPS Was $3.85. Expects Full Year 2013 Adjusted Diluted EPS To Increase To $4.10 - $4.20.
3. Cambrex Reports Fourth Quarter And Full Year 2012 Financial Results
4. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
5. Plaintiff in Prolift Vaginal Mesh Case Testifies She Can No Longer Work, Have Sex, or Function Normally, Rottenstein Law Group Reports
6. Mesa Labs Reports 18% Increase in Third Quarter Revenues
7. Cardinal Health Reports Fiscal 2013 Second-Quarter Results
8. Luminex Corporation Reports Fourth Quarter And Full Year 2012 Results
9. InspireMD Reports Results for Period Ended Dec. 31, 2012
10. BRICS NPWT Market and Pressure Relief Devices Industry Analysis in New Research Reports at ReportsnReports.com
11. Trimedyne Reports Financial Results For The Quarter And Fiscal Year Ended September 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , 20 de octubre de 2014  PneumRx, ... campo de la pulmonología intervencional, anunció hoy la ... casi 3 meses antes de lo programado. El Estudio ... de dispositivo de investigación (IDE) aprobada por la ... sistema de espiral de reducción de volumen pulmonar ...
(Date:10/20/2014)... BRIDGEWATER, N.J. , Oct. 20, 2014 ... delivery technology designed for patients with Type 2 diabetes, ... Health Supply Chain Excellence Award. The award was presented ... Conference in Columbus, Ohio . ... recipients are judged across a variety of metrics specifically ...
(Date:10/20/2014)... Oct. 20, 2014 Lpath, Inc. (NASDAQ: ... bioactive lipid-targeted therapeutics, received official notification from the European ... another key patent supporting its iSONEP™ and ASONEP™ ... European patent No. 2087002, claims compositions of matter ... two lead compounds, iSONEP and ASONEP. Sonepcizumab is ...
Breaking Medicine Technology:PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4
(Date:10/20/2014)... 2014 hc1.com today announced the ... solution that enables healthcare organizations of all sizes ... customer relationship management (“CRM”) solution. , Designed from ... of the healthcare industry, the hc1 Healthcare Relationship ... patients by combining healthcare CRM, HIPAA-compliant collaboration, and ...
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Principle ... years, takes pride in manufacturing top-of-the-line absorbent products. ... image of its most popular brand, Tranquility® Premium Protection ... created a new website, gave its packaging a new ... bring the brand message to the public. , The ...
(Date:10/20/2014)... Succeed is proud to announce that they ranked ... the Every Body Walk! campaign by Kaiser Permanente. ... encourages workers to be more active outside of the workplace. ... at the end of September, was a friendly competition between ... Participating companies gave their staff pedometers and each day, ...
(Date:10/20/2014)... 2014 Unveiled at the Sept. 18 board ... conservatively estimates member hospital ROI on membership dues at 12.5. ... Center provides $12.50 in value to member hospitals. The calculation ... Member Dues)/Member Dues. , “This is the first time ... we think the methodology is really sound,” said Bill ...
(Date:10/20/2014)... Silver Spring, Maryland, USA (PRWEB) October 20, 2014 ... readers or to track interventions? Here comes a wonderful ... leading mobile app development company helped its ... track Intervention more efficiently. The app is designed for ... iPad, and iPod touch. This app is optimized for ...
Breaking Medicine News(10 mins):Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
... Sam Smith as the new Chief Executive Officer of the international ... the International Board of Directors on Tuesday. , ... ... the unanimous confirmation of Sam Smith as the new Chief Executive ...
... Healthcare IT provider grows its operations in the Middle East , ... Systems Corporation (NYSE: PER ) ( www.perotsystems.com ) today ... to manage the pilot deployment of VistA - an open source ... a clinic in the capital, Amman. , ...
... EMPHYSEMA AT RISK FOR OSTEOPOROSIS , New research shows ... includes emphysema and chronic bronchitis, may also be at ... scans and pulmonary function tests on 65 male patients ... compare vertebral bone density with percentage of low attenuation ...
... D. England, MD, Professor and Chairman of Neurology at ... is the principal investigator of two studies recommending ... nerve disorder that to this time had few evidence-based ... two separate papers in the December 3, 2008 online ...
... The American Society of Hematology (ASH) will host its ... Marriott on Thursday, December 4, 2008, beginning at 8:00 ... hematology, the biological sciences, and medical research, is held ... year, students will have the opportunity to explore research ...
... N.J., Dec. 3 MedQuist Inc. (Nasdaq: MEDQ ... world, is pleased to announce the positive resolution of several ... Resolution of the DOJ Investigation , ... an administrative HIPAA subpoena for documents from the United States ...
Cached Medicine News:Health News:New CEO Takes Helm at Mercy Ships 2Health News:New CEO Takes Helm at Mercy Ships 3Health News:Perot Systems Awarded Contract to Implement Health Information System in Kingdom of Jordan 2Health News:Perot Systems Awarded Contract to Implement Health Information System in Kingdom of Jordan 3Health News:Journal CHEST: December highlighted studies 2Health News:LSUHSC's England leads development of new testing guidelines for common nerve disorder 2Health News:ASH Holds a Special Symposium to Interest High School Students in Biomedical Research 2Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 2Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 3Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 4Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 5Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 6
Antiseptic - Antibacterial Sudsing Cleanser...
... This requiring no water for ... hand hygiene to physically clean ... is either not an option ... allows you to return to ...
BETASEPT® Scrub 4% is for surgical handscrubbing, healthcare personnel hand-washing, preoperative patient prepping and general skin degerming....
... Scrub Care® Brand soaps, emulsions, washes ... ultimate in healthy skin care, helping ... skin healthy and soft even with ... not contain petroleum-based substances that can ...
Medicine Products: